These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22978312)

  • 1. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory.
    Cassagne C; Cella AL; Suchon P; Normand AC; Ranque S; Piarroux R
    Med Mycol; 2013 May; 51(4):371-7. PubMed ID: 22978312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of mass spectrometry: MALDI-TOF MS for fast and reliable yeast identification].
    Relloso MS; Nievas J; Fares Taie S; Farquharson V; Mujica MT; Romano V; Zarate MS; Smayevsky J
    Rev Argent Microbiol; 2015; 47(2):103-7. PubMed ID: 25882136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genus-level identification of dermatophytes by MALDI-TOF MS after 2 days of colony growth.
    Intra J; Sarto C; Tiberti N; Besana S; Savarino C; Brambilla P
    Lett Appl Microbiol; 2018 Aug; 67(2):136-143. PubMed ID: 29679385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Bruker Biotyper and VITEK MS Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Systems Using a Formic Acid Extraction Method to Identify Common and Uncommon Yeast Isolates.
    Lee HS; Shin JH; Choi MJ; Won EJ; Kee SJ; Kim SH; Shin MG; Suh SP
    Ann Lab Med; 2017 May; 37(3):223-230. PubMed ID: 28224768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine identification and mixed species detection in 6,192 clinical yeast isolates.
    Cassagne C; Normand AC; Bonzon L; L'Ollivier C; Gautier M; Jeddi F; Ranque S; Piarroux R
    Med Mycol; 2016 Mar; 54(3):256-65. PubMed ID: 26613703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database.
    Fraser M; Brown Z; Houldsworth M; Borman AM; Johnson EM
    Med Mycol; 2016 Jan; 54(1):80-8. PubMed ID: 26591008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for non-albicans Candida and uncommon yeast isolates.
    Teke L; Barış A; Bayraktar B
    J Microbiol Methods; 2021 Jun; 185():106232. PubMed ID: 33961963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Bader O; Weig M; Taverne-Ghadwal L; Lugert R; Gross U; Kuhns M
    Clin Microbiol Infect; 2011 Sep; 17(9):1359-65. PubMed ID: 20946411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of MALDI-TOF MS for requalification of a Candida clinical isolates culture collection.
    Lima-Neto R; Santos C; Lima N; Sampaio P; Pais C; Neves RP
    Braz J Microbiol; 2014; 45(2):515-22. PubMed ID: 25242936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new extraction protocol for yeast identification by mass spectrometry.
    Gouriet F; Ghiab F; Couderc C; Bittar F; Tissot Dupont H; Flaudrops C; Casalta JP; Sambe-Ba B; Fall B; Raoult D; Fenollar F
    J Microbiol Methods; 2016 Oct; 129():61-65. PubMed ID: 27498228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory.
    Bizzini A; Durussel C; Bille J; Greub G; Prod'hom G
    J Clin Microbiol; 2010 May; 48(5):1549-54. PubMed ID: 20220166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of Gram's stain, PNA-FISH and Sepsityper with MALDI-TOF MS for the identification of yeast direct from positive blood cultures.
    Gorton RL; Ramnarain P; Barker K; Stone N; Rattenbury S; McHugh TD; Kibbler CC
    Mycoses; 2014 Oct; 57(10):592-601. PubMed ID: 24862948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.
    Sendid B; Ducoroy P; François N; Lucchi G; Spinali S; Vagner O; Damiens S; Bonnin A; Poulain D; Dalle F
    Med Mycol; 2013 Jan; 51(1):25-32. PubMed ID: 22703164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Cassagne C; Ranque S; Normand AC; Fourquet P; Thiebault S; Planard C; Hendrickx M; Piarroux R
    PLoS One; 2011; 6(12):e28425. PubMed ID: 22194834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of MALDI-ToF mass spectrometry for yeast identification: a multicenter study.
    Normand AC; Gabriel F; Riat A; Cassagne C; Bourgeois N; Huguenin A; Chauvin P; De Geyter D; Bexkens M; Rubio E; Hendrickx M; Ranque S; Piarroux R
    Med Mycol; 2020 Jul; 58(5):639-649. PubMed ID: 31579924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.
    Arastehfar A; Daneshnia F; Kord M; Roudbary M; Zarrinfar H; Fang W; Hashemi SJ; Najafzadeh MJ; Khodavaisy S; Pan W; Liao W; Badali H; Rezaie S; Zomorodian K; Hagen F; Boekhout T
    Front Cell Infect Microbiol; 2019; 9():21. PubMed ID: 30828570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison and optimization of two MALDI-TOF MS platforms for the identification of medically relevant yeast species.
    Pence MA; McElvania TeKippe E; Wallace MA; Burnham CA
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1703-12. PubMed ID: 24800928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification.
    Duyvejonck H; Cools P; Decruyenaere J; Roelens K; Noens L; Vermeulen S; Claeys G; Decat E; Van Mechelen E; Vaneechoutte M
    PLoS One; 2015; 10(8):e0132149. PubMed ID: 26295947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory comparison of sample preparation methods, database expansions, and cutoff values for identification of yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry using a yeast test panel.
    Vlek A; Kolecka A; Khayhan K; Theelen B; Groenewald M; Boel E; ; Boekhout T
    J Clin Microbiol; 2014 Aug; 52(8):3023-9. PubMed ID: 24920782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of mass spectrometry for the identification of clinically interesting yeasts].
    Galán F; García-Agudo L; Guerrero I; Marín P; García-Tapia A; García-Martos P; Rodríguez-Iglesias M
    Enferm Infecc Microbiol Clin; 2015; 33(6):372-8. PubMed ID: 25444360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.